Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE: 688131)
Health Care · Life Sciences Tools & Services · CN
CN¥93.16
-6.34% today · +23.4% 1Y
Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE: 688131) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.97B and employs 4,540 people.
Over the last twelve months the share price has gained 23.4%, trading between 59.68 and 111.30.
Tweenvest scores Shanghai Haoyuan Chemexpress Co., Ltd. across four factors: quality 60/100, value 23/100, growth 98/100, dividend 8/100. Its strongest factor is growth.
688131 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.97B
- Revenue (TTM)
- $473.14M
- P/E
- 76.36
- EPS
- 1.22
- Dividend yield
- 0.26%
- Beta (5Y)
- 0.66
- 52-week high
- CN¥111.30
- 52-week low
- CN¥59.68
- Avg volume (3M)
- —
- Shares outstanding
- 213.23M
- Employees
- 4,540
- Next earnings
- —
About Shanghai Haoyuan Chemexpress Co., Ltd.
Shanghai Haoyuan Chemexpress Co., Ltd. is dedicated to the innovation and advancement of key compounds for the pharmaceutical industry, focusing on small molecule drugs and their essential intermediates. The company's production capabilities encompass active pharmaceutical ingredients (APIs) and their precursors, various vitamin D series substances, as well as specialized chemical building blocks and life science compounds tailored for contract research organizations (CROs). Established in 2006, its primary operational base is located in Shanghai, China.
- ISIN
- CNE1000051J4
- Founded
- 2006
- Listed since
- Jun 8, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| InSilico Medicine Cayman TopCoSEHK: 3696 | $3.60B | HK$49.00 | +1.58% |
| Siegfried Holding AGSWX: SFZN | $3.56B | CHF67.50 | -4.05% |
| Tecan Group AGSWX: TECN | $3.49B | CHF235.00 | +1.64% |
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.27B | Rs1,487.90 | -3.46% |
| Oxford Nanopore Technologies plcLSE: ONT | $2.75B | £2.13 | +6.27% |
| HitGen Inc.SHSE: 688222 | $2.48B | CN¥41.45 | -1.12% |
| GemPharmatech Co., Ltd.SHSE: 688046 | $2.12B | CN¥34.63 | -8.72% |
| Shanghai InnoStar Bio-tech Co., Ltd.SHSE: 688710 | $2.10B | CN¥99.80 | -5.13% |
Figures last refreshed Oct 11, 2026.